Corona vaccine may come soon for children, Bharat Biotech has completed the second-third phase of the vaccine trial


Corona virus vaccine may come soon for children in India. On Tuesday, Bharat Biotech said the Phase II-III trial of the company’s anti-Covid vaccine Covaxin for use on children below 18 years of age has been completed and is expected to submit the data to the Drug Controller General of India (DCGI) by next week. have hope.

Krishna Ella, chairman and managing director, Bharat Biotech International Ltd, said production of covaccine will reach 55 million doses in October, up from 35 million doses in September. He also said that the Phase II trial of the company’s anti-Covid-19 intranasal vaccine (nasal vaccine) is expected to be completed by next month.

Alla said, Phase II-III trials of children’s vaccines have been completed. The data is being analyzed. We will hand over the data (to the regulator) by next week. The number of volunteers is about one thousand. He said that the intranasal vaccine can elicit an immune response in the nose itself which is the gateway to the corona virus and thus provide protection against disease, infection and transmission.

According to Alla, the intranasal vaccine is being tested on three groups, one of which was given the covaccine vaccine as the first dose and the intranasal vaccine as the second dose i.e. the nasal vaccine. He said that in this way only the intranasal vaccine has been given to the second group, while the third group has been given intranasal and Covaccine vaccine at an interval of 28 days. Alla informed that the test will be done on 650 volunteers.


On the production level of Covaccine, Alla said that manufacturing 100 million doses per month would be possible only when other manufacturing partners are ready with safety and other parameters. Bharat Biotech has tied up with Indian Immunologicals and Hester Biosciences to manufacture Covaccine.

In response to a question, he said that we are supplying 3.5 crore doses every month. From next month, we will supply five and a half crore doses. Production is going on fast in Bangalore. On exports of the vaccine to other countries, Alla said that the company is ready to export the vaccine if the Center allows, though the company is in no rush to venture to overseas markets.

According to him, the focus of the government is on meeting the needs of the country. Union Health Minister Mansukh Mandaviya on Monday said that India will resume exports of additional COVID-19 vaccines next month to meet its commitment under the ‘Vaccine Friendship’ program and the global ‘Covax’ initiative, but the country’s people Immunization remains the top priority of the government.



Show More

Related Articles

Leave a Reply

Back to top button